GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » 6-1 Month Momentum %

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) 6-1 Month Momentum % : -35.69% (As of Jun. 24, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Staidson (Beijing) Biopharmaceuticals Co 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-24), Staidson (Beijing) Biopharmaceuticals Co's 6-1 Month Momentum % is -35.69%.

The industry rank for Staidson (Beijing) Biopharmaceuticals Co's 6-1 Month Momentum % or its related term are showing as below:

SZSE:300204's 6-1 Month Momentum % is ranked worse than
81.99% of 1521 companies
in the Biotechnology industry
Industry Median: -5.47 vs SZSE:300204: -35.69

Competitive Comparison of Staidson (Beijing) Biopharmaceuticals Co's 6-1 Month Momentum %

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staidson (Beijing) Biopharmaceuticals Co's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's 6-1 Month Momentum % falls into.



Staidson (Beijing) Biopharmaceuticals Co  (SZSE:300204) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Staidson (Beijing) Biopharmaceuticals Co  (SZSE:300204) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Staidson (Beijing) Biopharmaceuticals Co 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Staidson (Beijing) Biopharmaceuticals Co's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Business Description

Traded in Other Exchanges
N/A
Address
Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.
Executives
Zhang Hong Shan Supervisors
Zheng Hong Supervisors
Cheng Jiang Hong Executives
Feng Yu Jing Executives
Ma Li Na Secretary, Director
Zhou Zhi Wen Director
Wang Huan Securities Affairs Representative
Zhang Rong Qin Executives
Xu Jiang Ping Executives
Cao Hai Yan Supervisors
Sun Yan Fang Executives
Jiang Li Xin Director
Gu Jian Ping Director
Xu Xiang Qing Supervisors
Gu Zhen Qi Director

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Headlines

No Headlines